Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,100 | 425,300 | 415,100 | 187,000 | 112,300 |
| Marketable Securities | 613,900 | 519,400 | 533,200 | 584,700 | 558,200 |
| Receivables | 157,100 | 156,900 | 148,400 | 148,600 | 126,600 |
| Inventories | 28,000 | 20,600 | 22,000 | 21,200 | 17,300 |
| Other current assets | 30,100 | 34,700 | 27,500 | 26,700 | 16,600 |
| TOTAL | $1,016,200 | $1,156,900 | $1,146,200 | $968,200 | $831,000 |
| Non-Current Assets | |||||
| PPE Net | 44,600 | 43,000 | 44,600 | 41,900 | 41,900 |
| Investments And Advances | 265,300 | 225,100 | 245,900 | 275,300 | 355,600 |
| Other Non-Current Assets | 408,600 | 77,600 | 78,900 | 76,500 | 77,500 |
| TOTAL | $718,500 | $345,700 | $369,400 | $393,700 | $475,000 |
| Total Assets | $1,734,700 | $1,502,600 | $1,515,600 | $1,361,900 | $1,306,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 168,700 | 170,500 | 137,100 | 125,900 | 141,300 |
| Other current liabilities | 17,800 | 15,500 | 16,400 | 14,400 | 15,200 |
| TOTAL | $186,500 | $611,000 | $573,000 | $140,300 | $565,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 317,900 | N/A | N/A | 414,100 | N/A |
| Other Non-Current Liabilities | 104,100 | 87,300 | 111,400 | 107,200 | 103,800 |
| TOTAL | $422,000 | $87,300 | $111,400 | $521,300 | $103,800 |
| Total Liabilities | $608,500 | $698,300 | $684,400 | $661,600 | $669,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,944 | 93,429 | 93,255 | 92,865 | 92,292 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -725,400 | -1,073,300 | -1,015,700 | -1,095,300 | -1,132,700 |
| Other shareholders' equity | 1,800 | 3,200 | 4,600 | -1,400 | 1,400 |
| TOTAL | $1,126,200 | $804,300 | $831,200 | $700,300 | $636,900 |
| Total Liabilities And Equity | $1,734,700 | $1,502,600 | $1,515,600 | $1,361,900 | $1,306,000 |